BioHarvest Sciences Inc.
BHST
$6.55
-$0.05-0.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.91M | -17.19M | -16.23M | -18.39M | -12.56M |
| Total Depreciation and Amortization | 1.25M | 1.13M | 992.00K | 844.00K | 840.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.53M | 9.25M | 8.43M | 9.45M | 2.45M |
| Change in Net Operating Assets | -555.00K | -475.00K | 287.00K | -345.00K | 755.00K |
| Cash from Operations | -6.68M | -7.29M | -6.53M | -8.45M | -8.52M |
| Capital Expenditure | -2.84M | -2.73M | -2.66M | -1.32M | -1.47M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -192.00K | -185.00K | -225.00K | -- | -- |
| Cash from Investing | -3.03M | -2.92M | -2.89M | -1.32M | -1.47M |
| Total Debt Issued | 3.31M | 7.10M | 8.38M | 12.82M | 13.52M |
| Total Debt Repaid | -1.27M | -502.00K | -433.00K | -410.00K | -364.00K |
| Issuance of Common Stock | 4.74M | 4.74M | 4.74M | 416.00K | 403.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.78M | 11.34M | 12.68M | 12.82M | 13.56M |
| Foreign Exchange rate Adjustments | -34.00K | 81.00K | 85.00K | 78.00K | 59.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.97M | 1.21M | 3.36M | 3.14M | 3.62M |